Sen-Jam Pharma Engages Destum for Strategic Partnerships on SJP-001 & SJP-002C
February 12, 2025
Sen-Jam Pharmaceutical, a pioneering biotech company dedicated to innovative anti-inflammatory solutions, is pleased to announce its engagement with Destum Partners, a leading advisory firm specializing